141
Loop Diuretics in Chronic Kidney Disease
Condition(s):Chronic Kidney DiseaseLast Updated:February 4, 2009Completed
Furosemide as an Intervention: 336 Clinical Trials, Page 15 of 34
Hide Studies Not Open or Pending
142
Prevention of Contrast-Induced Nephropathy
Condition(s):Contrast-induced Nephropathy; Acute Renal Failure; Chronic Renal FailureLast Updated:May 10, 2011Completed
143
The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients
Condition(s):Secondary Hyperparathyroidism; Chronic Kidney DiseaseLast Updated:October 26, 2017Unknown status
144
Diuretic Response in Advanced Heart Failure: Bolus Intermittent vs Continuous INfusion
Condition(s):Heart Failure NYHA Class III; Heart Failure NYHA Class IVLast Updated:July 19, 2018Completed
145
Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload
Condition(s):LeukemiaLast Updated:April 5, 2013Withdrawn
146
A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and Furosemide in Healthy Male Subjects
Condition(s):Healthy Male SubjectsLast Updated:March 14, 2023Not yet recruiting
147
Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury
Condition(s):Kidney Failures, AcuteLast Updated:March 28, 2016Withdrawn
148
Evaluation of Renal Sodium Excretion After Salt Loading in Heart Failure With Preserved Ejection Fraction
Condition(s):Heart Failure With Preserved Ejection FractionLast Updated:April 19, 2021Completed
149
Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure
Condition(s):Heart FailureLast Updated:December 23, 2022Recruiting
150
Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors
Condition(s):Neuroendocrine TumorsLast Updated:November 21, 2022Recruiting